Pathogenesis of invasive candidiasis

Current Opinion in Critical Care

Volumn 16, Issue 5, 2010, Pages 453-459

  Van De Veerdonk, Frank L ^a   Kullberg, Bart Jan ^a   Netea, Mihai G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Candida; Mucosa; Neutrophil; Th1; Th17

Indexed keywords

INFLAMMASOME; INTERLEUKIN 1; RECOMBINANT CYTOKINE; TUMOR NECROSIS FACTOR;

CANDIDA; CANDIDA ALBICANS; CELLULAR IMMUNITY; FUNGAL COLONIZATION; HELPER CELL; HOST RESISTANCE; HUMAN; IMMUNOTHERAPY; INVASIVE CANDIDIASIS; LEUKOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MUCOSA; NONHUMAN; PATHOGENESIS; REVIEW; TH1 CELL;

CANDIDA; CANDIDIASIS, INVASIVE; HUMANS; INTENSIVE CARE UNITS;

EID: 78449292335     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e32833e046e     Document Type: Review

References (79)

1. Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39:309-317.
2. Gudlaugsson O, Gillespie S, Lee K, et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003; 37:1172-1177.
3. Mitchison A. Will we survive? Sci Am 1993; 269:136-144.
4. Netea MG, Brown GD, Kullberg BJ, et al. An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol 2008; 6:67-78.
5. Tada H, Nemoto E, Shimauki H, et al. Saccharomyces cerevisiae and Candida albicans-derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14- and Toll-like receptor 4-dependent manner. Microbiol Immunol 2002; 2002:503-512.
6. Netea MG, Gow NA, Munro CA, et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Tolllike receptors. J Clin Invest 2006; 116:1642-1650.
7. Netea MG, de Graaf C, Vonk A, et al. The role of Toll-like receptors in the defense against disseminated candidiasis. J Infect Dis 2002; 185:1483-1489.
8. Jouault T, Ibata-Ombetta S, Takeuchi O, et al. Candida albicans phospho-lipomannan is sensed through Toll-like receptors. J Infect Dis 2003; 188:165-172.
9. Gantner BN, Simmons RM, Canavera SJ, et al. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med 2003; 197:1107-1117.
10. Brown GD, Herre J, Williams DL, et al. Dectin-1 mediates the biological effects of beta-glucans. J Exp Med 2003; 197:1119-1124.
11. Villamon E, Gozalbo D, Roig P, et al. Toll-like receptor-2 is essential in murine defenses against Candida albicans infections. Microbes Infect 2004; 6:1-7.
12. Netea MG, Sutmuller R, Hermann C, et al. Toll-like receptor 2 suppresses immunity against Candida albicans through induction ofIL-10 and regulatory T cells. J Immunol 2004; 172:3712-3718.
13. Bellocchio S, Montagnoli C, Bozza S, et al. The contribution of Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol 2004; 172:3059-3069.
14. van de Veerdonk FL, Netea MG, Jansen T, et al. Redundant role of TLR9 for anti-Candida host defense. Immunobiology 2008; 213:613-620.
15. Netea MG, van de Veerdonk F, Verschueren I, et al. Role ofTLR1 and TLR6 in the host defense against disseminated candidiasis. FEMS Immunol Med Microbiol 2008; 52:118-123.
16. Brown GD. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 2006; 6:33-43.
17. Stahl PD, Ezekowitz RA. The mannose receptor is a pattern recognition receptor involved in host defense. Curr Opin Immunol 1998; 10:50-55.
18. Heinsbroek SE, Taylor PR, Martinez FO, et al. Stage-specific sampling by pattern recognition receptors during Candida albicans phagocytosis. PLoS Pathog 2008; 4:e1000218.
19. Sato K, Yang XL, Yudate T, et al. Dectin-2 is a pattern recognition receptor for fungi that couples with the Fc receptor gamma chain to induce innate immune responses. J Biol Chem 2006; 281:38854-38866.
20. Means TK, Mylonakis E, Tampakakis E, et al. Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J Exp Med 2009; 206:637-653.
21. Jouault T, El Abed-El Behi M, Martinez-Esparza M, et al. Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling. J Immunol 2006; 177:4679-4687.
22. Wells CA, Salvage-Jones JA, Li X, et al. The macrophage-inducible C-type lectin, mincle, is an essential component of the innate immune response to Candida albicans. J Immunol 2008; 180:7404-7413.
23. van de Veerdonk FL, Kullberg BJ, van der Meer JW, et al. Host-microbe interactions: innate pattern recognition of fungal pathogens. Curr Opin Microbiol 2008; 11:305-312.
24. Dongari-Bagtzoglou A, Fidel PL Jr. The host cytokine responses and protective immunity in oropharyngeal candidiasis. J Dent Res 2005; 84:966-977.
25. Mostefaoui Y, Bart C, Frenette M, et al. Candida albicans and Streptococcus salivarius modulate IL-6, IL-8, and TNF-alpha expression and secretion by engineered human oral mucosa cells. Cell Microbiol 2004; 6:1085-1096.
26. Dongari-Bagtzoglou A, Kashleva H. Candida albicans triggers interleukin-8 secretion by oral epithelial cells. Microb Pathog 2003; 34:169-177.
27. Li L, Dongari-Bagtzoglou A. Epithelial GM-CSF induction by Candida glabrata. J Dent Res 2009; 88:746-751.
28. Pivarcsi A, Bodai L, Rethi B, et al. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol 2003; 15:721-730.
29. Dongari-Bagtzoglou A, Villar CC, Kashleva H. Candida albicans-infected oral epithelial cells augment the antifungal activity of human neutrophils in vitro. Med Mycol 2005; 43:545-549.
30. Weindl G, Naglik JR, Kaesler S, et al. Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling. J Clin Invest 2007; 117:3664-3672.
31. Milner JD, Brenchley JM, Laurence A, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008; 452:773-776.
32. Minegishi Y, Saito M, Tsuchiya S, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007; 448:1058-1062.
33. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008; 28:454-467.
34. Holland SM, DeLeo FR, Elloumi HZ, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007; 357:1608-1619.
35. Eyerich K, Foerster S, Rombold S, et al. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J Invest Dermatol 2008; 128:2640-2645.
36. Leibundgut-Landmann S, Gross O, Robinson MJ, et al. Syk- and CARD9- dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 2007; 8:630-638.
37. Ferwerda B, Ferwerda G, Plantinga TS, et al. Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 2009; 361:1760-1767.
38. Plantinga TS, van der Velden WJ, Ferwerda B, et al. Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients. Clin Infect Dis 2009; 49:724-732.
39. Glocker EO, Hennigs A, Nabavi M, et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 2009; 361:1727-1735.
40. van de Veerdonk FL, Marijnissen RJ, Kullberg BJ, et al. The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 2009; 5:329-340.
41. Saijo S, Ikeda S, Yamabe K, et al. Dectin-2 recognition of alpha-Mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 2010; 32:681-691.
42. Schoenen H, Bodendorfer B, Hitchens K, et al. Cutting edge: mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate. J Immunol 2010; 184:2756-2760.
43. Robinson MJ, Osorio F, Rosas M, et al. Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection. J Exp Med 2009; 206:2037-2051.
44. Herre J, Marshall AS, Caron E, et al. Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. Blood 2004; 104:4038-4045.
45. Ezekowitz RAB, Sieff CA, Dinauer MC, et al. Restoration of phagocyte function by interferon-g in X-linked chronic granulomatous disease occurs at the level of a progenitor cell. Blood 1990; 76:2443-2448.
46. Romani L, Montagnoli C, Bozza S, et al. The exploitation ofdistinct recognition receptors in dendritic cells determines the full range of host immune relationships with Candida albicans. Int Immunol 2004; 16:149-161.
47. van Bruggen R, Drewniak A, Jansen M, et al. Complement receptor 3, not Dectin-1, is the major receptor on human neutrophils for beta-glucan-bearing particles. Mol Immunol 2009; 47:575-581.
48. Yoon J, Ponikau JU, Lawrence CB, et al. Innate antifungal immunity of human eosinophils mediated by a beta 2 integrin, CD11b. J Immunol 2008; 181:2907-2915.
49. Blander JM, Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 2006; 440:808-812.
50. Romani L. Immunity to fungal infections. Nature Rev Immunol 2004; 4:1-13.
51. Yang Z, Marshall JS. Zymosan treatment of mouse mast cells enhances dectin-1 expression and induces dectin-1-dependentreactive oxygen species (ROS) generation. Immunobiology 2009; 214:321-330.
52. Aratani Y, Koyama H, Nyui S, et al. Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun 1999; 67:1828-1836.
53. Mansour MK, Levitz SM. Interactions of fungi with phagocytes. Curr Opin Microbiol 2002; 5:359-365.
54. Kennedy AD, Willment JA, Dorward DW, et al. Dectin-1 promotes fungicidal activity of human neutrophils. Eur J Immunol 2007; 37:467-478.
55. Reeves EP, Lu H, Jacobs HL, et al. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 2002; 416:291-297.
56. Kohatsu L, Hsu DK, Jegalian AG, et al. Galectin-3 induces death of Candida species expressing specific beta-1,2-linked mannans. J Immunol 2006; 177:4718-4726.
57. Netea MG, van Tits LJ, Curfs JH, et al. Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans. J Immunol 1999; 163:1498-1505.
58. Vonk AG, Netea MG, van Krieken JH, et al. Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis. J Infect Dis 2006; 193:1419-1426.
59. van Enckevort FH, Netea MG, Hermus AR, et al. Increased susceptibility to systemic candidiasis in interleukin-6 deficient mice. Med Mycol 1999; 37:419-426.
60. Romani L, Mencacci A, Cenci E, et al. Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J Exp Med 1996; 183:1345-1355.
61. Kaposzta R, Tree P, Marodi L, et al. Characteristics of invasive candidiasis in gamma interferon- and interleukin-4-deficient mice: role of macrophages in host defense against Candida albicans. Infect Immun 1998; 66:1708-1717.
62. Gallin JI, Farber JM, Holland SM, et al. Interferon-gamma in the managementof infectious diseases. Ann Int Med 1995; 123:216-222.
63. Balish E, Wagner RD, Vasquez-Torres A, et al. Candidiasis in interferon-gamma knock-out (IFN-gamma-/-) mice. J Infect Dis 1998; 178:478-487.
64. Lavigne LM, Schopf LR, Chung CL, et al. The role of recombinant IL-12 and IFN-gamma in the pathogenesis of a murine Candida albicans infection. J Immunol 1998; 160:284-292.
65. Netea MG, Vonk AG, van den Hoven M, et al. Differential role of IL-18 and IL- 12 in the host defense against disseminated Candida albicans infection. Eur J Immunol 2003; 33:3409-3417.
66. Gozalbo D, Gil ML. IFN-gamma in Candida albicans infections. Front Biosci 2009; 14:1970-1978.
67. van de Veerdonk FL, Kullberg BJ, Verschueren IC, et al. Differential effects of IL-17 pathway in disseminated candidiasis and zymosan-induced multiple organ failure. Shock 2010.
68. Huang W, Na L, Fidel PL, et al. Requirement of interleukin-17A for systemic anti-Candida albicans hostdefense in mice. J Infect Dis 2004; 190:624-631.
69. Lin L, Ibrahim AS, Xu X, et al. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog 2009; 5:e1000703.
70. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002; 10:417-426.
71. Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 2007; 14:10-22.
72. Gross O, Poeck H, Bscheider M, et al. Syk kinase signalling couples to the Nlrp3 inflammasome for antifungal host defence. Nature 2009; 459:433-436.
73. Hise AG, Tomalka J, Ganesan S, et al. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 2009; 5:487-497.
74. Lamkanfi M, Malireddi RK, Kanneganti TD. Fungal zymosan and mannan activate the cryopyrin inflammasome. J Biol Chem 2009; 284:20574-20581.
75. Joly S, Ma N, Sadler JJ, et al. Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome. J Immunol 2009; 183:3578-3581.
76. Mencacci A, Bacci A, Cenci E, et al. Interleukin 18 restores defective Th1 immunity to Candida albicans in Caspase 1-deficient mice. Infect Immun 2000; 68:5126-5131.
77. van deVeerdonkFL, Joosten LA, DevesaI, et al. Bypassing pathogen-induced inflammasome activation for the regulation of interleukin-1beta production by the fungal pathogen Candida albicans. J Infect Dis 2009; 199:1087-1096.
78. Joosten LA, Netea MG, Fantuzzi G, et al. Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta. Arthritis Rheum 2009; 60:3651-3662.
79. Coeshott C, Ohnemus C, Pilyavskaya A, et al. Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc Natl Acad Sci USA 1999; 96:6261-6266.